Covered recipient · General Payments record
MOHAMMAD OBADAH NAKAWAH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,887.75
- Reported across 258 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $784.53 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Behring | $158.78 | 6 |
| Lilly USA, LLC | $153.07 | 5 |
| EISAI INC. | $92.64 | 3 |
| HOSPIRA, INC. | $59.98 | 3 |
| ACADIA Pharmaceuticals Inc | $51.45 | 3 |
| Alexion Pharmaceuticals, Inc. | $47.36 | 2 |
| GE HEALTHCARE | $42.42 | 1 |
| Otsuka America Pharmaceutical, Inc. | $40.88 | 2 |
| PFIZER INC. | $35.04 | 2 |
| Lundbeck LLC | $27.16 | 1 |
| UCB, Inc. | $22.33 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.25 | 1 |
| ABBVIE INC. | $19.05 | 1 |
| Biogen, Inc. | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.05 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105096523 | CMS |
| ACADIA Pharmaceuticals Inc | $16.22 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147984946 | CMS |
| ACADIA Pharmaceuticals Inc | $18.45 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147984948 | CMS |
| ACADIA Pharmaceuticals Inc | $16.78 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147984950 | CMS |
| Alexion Pharmaceuticals, Inc. | $29.04 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094008340 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.32 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093984615 | CMS |
| Biogen, Inc. | $14.12 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104835401 | CMS |
| CSL Behring | $25.28 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134653993 | CMS |
| CSL Behring | $21.46 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134654001 | CMS |
| CSL Behring | $32.60 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134654105 | CMS |
| CSL Behring | $29.24 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134654111 | CMS |
| CSL Behring | $24.86 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134654113 | CMS |
| CSL Behring | $25.34 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134654119 | CMS |
| Eisai Inc. | $24.69 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110767743 | CMS |
| Eisai Inc. | $34.02 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110767741 | CMS |
| Eisai Inc. | $33.93 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110767745 | CMS |
| GE HEALTHCARE | $42.42 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144681579 | CMS |
| HOSPIRA, INC. | $20.13 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131406771 | CMS |
| HOSPIRA, INC. | $18.33 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131570221 | CMS |
| HOSPIRA, INC. | $21.52 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131225680 | CMS |
| Lilly USA, LLC | $47.96 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135263553 | CMS |
| Lilly USA, LLC | $27.37 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135263557 | CMS |
| Lilly USA, LLC | $17.12 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135217107 | CMS |
| Lilly USA, LLC | $18.94 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135254494 | CMS |
| Lilly USA, LLC | $41.68 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135254498 | CMS |
| Lundbeck LLC | $27.16 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145949382 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.29 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118948492 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.59 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118948494 | CMS |
| PFIZER INC. | $19.84 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131278389 | CMS |
| PFIZER INC. | $15.20 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132102287 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.25 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137641114 | CMS |
| UCB, Inc. | $22.33 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143111132 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.